| Model Number |
2P56-22 |
| Medical Device Problem Code |
High Test Results (2457)
|
| Health Effect - Clinical Code |
No Known Impact Or Consequence To Patient (2692)
|
| Date of Event |
08/28/2020
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Patient information, 1.Patient identifier = (b)(6) an evaluation is in process.A follow-up report will be submitted when the evaluation is complete.There was no additional patient information provided due to privacy issues.
|
| |
|
Event or Problem Description
|
|
The customer reported falsely elevated ldh results on one patient generated on the architect analyzer.The results provided were: on (b)(6) 2020 sid (b)(6) initial = 570 u/l (normal range 120-240 u/l) / retested = 193 and 207 u/l.There was no reported impact to patient management.
|
| |
|
Additional Manufacturer Narrative
|
|
The customer reported falsely elevated results while using lactate dehydrogenase on the architect processing module c803666.Return testing was not completed as returns were not available.The trend review by the product list number (ln 02p56-22) found no trends related to this issue.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation, no systemic issue or deficiency of the lactate dehydrogenase assay, list number 02p56-22, was identified.
|
| |
|
Search Alerts/Recalls
|